NewsRx

Search our medical news database

Cancer Research

Data from South Korea and Germany advance knowledge in cancer research

Published in Cancer Weekly, May 22nd, 2006

Cancer data are the focus of recent research from South Korea and Germany.

Study 1: Recent research from South Korea has chronicled the growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus (SFV) vector in glioblastoma cells.

"The gene delivery of multiple tumor suppressors can provide efficient tumor therapy in the case of malignant human glioblastomas containing multiple genetic alteration and inactivation.

"As such, the current study presents a new delivery system that can simultaneously express three antitumor genes using a SFV vector in the expectation of combined or synergistic effects of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook